Hsp90 is a molecular chaperone that heals diverse array of biomolecules ranging from multiple oncogenic proteins to the ones responsible for development of resistance to chemotherapeutic agents. Moreover they are over-expressed in cancer cells as a complex with co-chaperones and under-expressed in normal cells as a single free entity. Hence inhibitors of Hsp90 will be more effective and selective in destroying cancer cells with minimum chances of acquiring resistance to them. In continuation of our goal to rationally develop effective small molecule azomethines against Hsp90, we designed few more compounds belonging to the class of 2,4-dihydroxy benzaldehyde derived imines (1-13) with our validated docking protocol. The molecules exhibiting...
The molecular chaperone heat shock protein 90 (HSP90) has emerged as an exciting molecular target. D...
none35noRuthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihy...
Background: Heat shock protein 90 (HSP90) is a well-known target for cancer therapy. In a previous w...
Heat shock protein 90 (Hsp90) is an emerging attractive target for the discovery of novel cancer the...
The ubiquitously expressed heat shock protein 90 is an encouraging target for the development of nov...
Hsp90 has become the target of intensive investigation, as inhibition of its function has the abilit...
Abstract: The 90 kDa heat shock protein (Hsp90) is a molecular chaperone that is critical cellular s...
This thesis represents a discussion of the advancements made in the area of Hsp90 therapeutics, and ...
As the most abundant heat shock protein (HSP), Hsp90 is actively involved in tumor cell growth and v...
The 90 kDa Heat Shock Protein (Hsp90) has emerged as a major therapeutic target for a number of dise...
The heat shock protein 90 (Hsp90) family of molecular chaperones is responsible for the conformation...
Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycum...
<p>To identify new HSP90 inhibitors, the ATP binding site of the N-domain of HSP90 was targeted by m...
Background: Heat shock protein 90 (HSP90) is a well-known target for cancer therapy. In a previous w...
Heat shock protein 90 (Hsp90) is a significant target in the development of rational cancer therapy ...
The molecular chaperone heat shock protein 90 (HSP90) has emerged as an exciting molecular target. D...
none35noRuthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihy...
Background: Heat shock protein 90 (HSP90) is a well-known target for cancer therapy. In a previous w...
Heat shock protein 90 (Hsp90) is an emerging attractive target for the discovery of novel cancer the...
The ubiquitously expressed heat shock protein 90 is an encouraging target for the development of nov...
Hsp90 has become the target of intensive investigation, as inhibition of its function has the abilit...
Abstract: The 90 kDa heat shock protein (Hsp90) is a molecular chaperone that is critical cellular s...
This thesis represents a discussion of the advancements made in the area of Hsp90 therapeutics, and ...
As the most abundant heat shock protein (HSP), Hsp90 is actively involved in tumor cell growth and v...
The 90 kDa Heat Shock Protein (Hsp90) has emerged as a major therapeutic target for a number of dise...
The heat shock protein 90 (Hsp90) family of molecular chaperones is responsible for the conformation...
Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycum...
<p>To identify new HSP90 inhibitors, the ATP binding site of the N-domain of HSP90 was targeted by m...
Background: Heat shock protein 90 (HSP90) is a well-known target for cancer therapy. In a previous w...
Heat shock protein 90 (Hsp90) is a significant target in the development of rational cancer therapy ...
The molecular chaperone heat shock protein 90 (HSP90) has emerged as an exciting molecular target. D...
none35noRuthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihy...
Background: Heat shock protein 90 (HSP90) is a well-known target for cancer therapy. In a previous w...